The Predictive Value of Plasma Neutrophil Gelatinase-Associated Lipocalin on Cardiovascular Death and All-Cause Mortality Might Be Mediated by Leukocytosis
We read with interest the paper by Daniels et al. (1) , who concluded that higher levels of plasma neutrophil gelatinaseassociated lipocalin (NGAL) are associated independently with an increased risk of cardiovascular death and all-cause mortality in a cohort of older community-dwelling adults. The lack of correlation with renal function led the authors to conclude that plasma NGAL provides prognostic information that is independent of glomerular filtration rate, and the modest correlation with C reactive protein also underlines that NGAL would reflect a pathophysiological process distinct from inflammation. We (2), as well as others (3), have shown independently that serum, but not urinary, NGAL levels are influenced dramatically by leukocytosis, especially by a high neutrophil count. The paper by Daniels et al. (1) lacks data regarding leukocyte or neutrophil counts, and therefore, it cannot be excluded that the significant role of plasma NGAL in predicting mortality and cardiovascular outcomes observed in this study might have been mediated largely by these untested parameters, because leukocytosis is per se a significant predictor of noninfective mortality and morbidity, particularly resulting from cardiovascular or cerebrovascular causes (4) 
Reply
We thank Drs. Lippi and Cervellin for their interest in our study (1) . Although leukocyte count was not measured at the 1992 through 1996 Rancho Bernardo study visit, 802 (58%) of the 1,393 individuals in our study did undergo leukocyte count measurement in a previous visit approximately 4 years earlier. In these individuals, the correlation between potentially log (neutrophil gelatinaseassociated lipocalin) and leukocyte count was only 0.14. We repeated the multivariable Cox proportional hazard models with leukocyte count included as a covariate, and the results were essentially unchanged, with only a very slight attenuation of the risk estimates. Neutrophil gelatinase-associated lipocalin was still a strong, independent predictor of cardiovascular disease death and of the combined cardiovascular end point in fully adjusted models that included leukocyte count. In addition, the association with all-cause mortality remained significant in models adjusted for age, sex, and leukocyte count, with borderline significance after adjusting further for other risk factors. Thus, neutrophil gelatinaseassociated lipocalin seems to be an independent predictor of cardio-
